Poultry Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The poultry healthcare market is expected to witness a CAGR of 8.5% during the forecast period.

COVID-19 has affected the poultry healthcare market significantly. The supply chain was disrupted due to the restriction imposed worldwide, leading to difficulties in moving animal products, such as meat, milk, and eggs, to markets during the initial period. For instance, according to an article published by MDPI, in March 2022, COVID-19 severely impacted the poultry production sector. The impact was more severe in developing countries due to the dependency on exporting necessary supplies such as feed, vaccines, and drugs. Thus, trade limitations led to the economic crisis, which adversely impacted poultry industries, including the agricultural value chain, such as the livestock production sector. However, with the declining COVID-19 cases, there has been an increase in trade and agricultural production, leading to proper care and nutrition for the chickens, eventually rising the demand for poultry healthcare, thereby driving the growth of the market over the forecast period.

Factors that are propelling the market growth are the increasing initiatives by government and animal welfare associations, the rising occurrence of zoonotic diseases, and the rise in demand for poultry-derived food products. The number of zoonotic disease cases in poultry animals has risen significantly in recent years. For instance, according to WHO update in December 2022, globally, till November 2022, there have been 868 cases of human infection with avian influenza A(H5N1) virus reported from 21 countries and as of December 2022, a total of 240 cases of human infection with avian influenza A(H5N1) virus have been reported from four countries within the Western Pacific Region. Thus, the rising occurrence of avian influenza is expected to increase the risk of spreading the virus to humans, which in turn is anticipated to increase the demand for effective diagnostic and therapeutics to prevent the impact of the virus in birds, thereby fueling the market growth.

Additionally, an article published by Frontiers Media S.A. in November 2021, reported that both commercial broilers and layers tested positive for Newcastle disease virus (NDV) using the M gene rRT-PCR. In addition, as per the same source, based on M gene identification, flocks with mild respiratory issues had a greater prevalence of Newcastle disease virus (15.7%), followed by healthy (9.1%) and sick (3.0%) flocks, in India. Thus, the high prevalence of Newcastle disease in poultry birds is expected to increase the demand for early detection and treatment of the disease to avoid its transmission to humans, which in turn is anticipated to propel the market growth over the forecast period.

Furthermore, the rising company activities in developing products and increasing product launches also contribute to the market growth. For instance, in October 2021, Cargill launched poultry feed with essential oils, Nutrena Naturewise, for healthy flocks and maximized egg production. The improved Nutrena NatureWise formulas help in boosting the overall wellness, happiness, and productivity of backyard chickens. Also, in October 2020, the company Boehringer Ingelheim Animal Health launched the VAXXITEK HVT+IBD+ILT vaccine against Laryngotracheitis, Marek's Disease, and Infectious Bursal Disease.

However, the use of counterfeit medicines and lack of veterinarians, and a shortage of skilled farm workers are likely to impede the market growth over the forecast period.

Poultry Healthcare Market Trends

The Vaccines Segment is Expected to Show Better Growth Over the Forecast Period

The vaccine segment is expected to witness significant growth in the poultry healthcare market over the forecast period owing to increased chicken meat production, the rising prevalence of zoonotic diseases, and increased investment in vaccine development by key players to prevent zoonotic diseases. For instance, according to the United States Department of Agriculture, Foreign Agricultural Service, January 2023 report, with upward improvements for the United Kingdom, Thailand, and Mexico, global chicken meat production for 2023 is estimated to be 102.9 million tons. Similarly, global chicken meat exports for 2023 were estimated to be 14.0 million tons. With the increasing chicken meat production, the need to opt for preventive vaccines to prevent diseases in poultry also increases, which is expected to help the segmental growth over the forecast period.

In addition, the rising company activities in developing vaccines for preventing poultry animals from infections and diseases are also contributing to the market growth. For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD). Also, in May 2021, Elanco Health Incorporated signed four contracts with EVAH Corp. to acquire and develop technologies in animal health. The four contracts between EVAH and Elanco relate to four products in development (two feed additives and two vaccines) targeting three species: salmon, swine, and poultry.

North America Shows a Significant Market Growth Over the Forecast Period

North America is expected to dominate the global poultry healthcare market over the forecast period, owing to factors such as the rising demand for poultry-derived food products and the rising occurrence of zoonotic diseases in the region. For instance, according to the United States Department of Agriculture, Foreign Agricultural Service, January 2023 report, chicken meat production in the United States increased from 20,391 in 2021 to 20,845 in 2022, and chicken meat production in Mexico increased from 3,815 in 2021 to 3,900 in 2022. With the increasing poultry production, the number of poultry affected by diseases is also expected to increase. To counter this, the farmers are expected to opt for poultry healthcare, driving market growth over the forecast period.

Additionally, per an article published by the Association of Food and Drug Officials in January 2022, the avian influenza virus has found its way to Canada's Atlantic coast in the Province of Newfoundland and Labrador. Maine has the potential to be the next hotspot for this avian influenza if certain preventative measures are not taken immediately. To stop the spread of the disease and prevent poultry from infections, veterinarians suggest healthcare measures. This is expected to increase the market growth over the forecast period.

Furthermore, the rising product launches in the region are expected to boost the market growth. For instance, in August 2021, Huvepharma Canada Corporation Inc. launched a new vaccine, Clostridium Perfringens Type A, a live vaccine, in Canada. The vaccine can be administered to broiler chickens at the day of age or older for necrotic enteritis (NE) due to Clostridium perfringens type A in broiler chickens. Also, in January 2020, Boehringer Ingelheim’s United States Animal Health Business launched a vaccine, VAXXITEK HVT+IBD+ND, to protect poultry from three diseases, in India. It provides a strong immune foundation and optimized protection against Marek’s Disease, Infectious Bursal Disease (classic and variant types), and Newcastle Disease.

Poultry Healthcare Industry Overview

The poultry healthcare market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally, including Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, Merck & Co. Inc., IDEXX Laboratories, Inc., Megacorp Diagnostik GmbH, Thermo Fisher Scientific Inc., Virbac, and Zoetis Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.